Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Assets AverageEnterprise ValueEquity AverageEquity RatioInvested CapitalReturn on AssetsReturn on Capital EmployedReturn on Equity

Aethlon Medical (AEMD) FCF Margin (2016 - 2023)

Aethlon Medical filings provide 13 years of FCF Margin readings, the most recent being 515.11% for Q1 2023.

  • On a quarterly basis, FCF Margin rose 2473249.0% to 515.11% in Q1 2023 year-over-year; TTM through Mar 2023 was 1993.62%, a 144539.0% increase, with the full-year FY2023 number at 1993.62%, up 144539.0% from a year prior.
  • FCF Margin hit 515.11% in Q1 2023 for Aethlon Medical, up from 25247.61% in the prior quarter.
  • In the past five years, FCF Margin ranged from a high of 310.67% in Q4 2019 to a low of 25247.61% in Q1 2022.
  • Median FCF Margin over the past 5 years was 1599.05% (2021), compared with a mean of 5359.1%.
  • Biggest five-year swings in FCF Margin: plummeted -1869287bps in 2022 and later soared 2473249bps in 2023.
  • Aethlon Medical's FCF Margin stood at 310.67% in 2019, then dropped by -15bps to 356.7% in 2020, then plummeted by -4447bps to 16218.1% in 2021, then plummeted by -56bps to 25247.61% in 2022, then soared by 98bps to 515.11% in 2023.
  • The last three reported values for FCF Margin were 515.11% (Q1 2023), 25247.61% (Q1 2022), and 16218.1% (Q4 2021) per Business Quant data.